HAEM5:Volunteer Assignments and Opportunities: Difference between revisions
| [unchecked revision] | [unchecked revision] |
No edit summary |
No edit summary |
||
| Line 888: | Line 888: | ||
| | | | ||
|- | |- | ||
|Mature plasmacytoid dendritic cell proliferation associated with myeloid neoplasm | |[[HAEM5:Mature plasmacytoid dendritic cell proliferation associated with myeloid neoplasm|Mature plasmacytoid dendritic cell proliferation associated with myeloid neoplasm]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 904: | Line 904: | ||
|NEW (No Prior) | |NEW (No Prior) | ||
|- | |- | ||
|Blastic plasmacytoid dendritic cell neoplasm | |[[HAEM5:Blastic plasmacytoid dendritic cell neoplasm|Blastic plasmacytoid dendritic cell neoplasm]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 920: | Line 920: | ||
|Previously within myeloid section under JH/MS editors | |Previously within myeloid section under JH/MS editors | ||
|- | |- | ||
|Langerhans cell histiocytosis | |[[HAEM5:Langerhans cell histiocytosis|Langerhans cell histiocytosis]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 936: | Line 936: | ||
|Date completed by author: 04/28/2022 | |Date completed by author: 04/28/2022 | ||
|- | |- | ||
|Langerhans cell sarcoma | |[[HAEM5:Langerhans cell sarcoma|Langerhans cell sarcoma]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 952: | Line 952: | ||
|Date completed by author: 04/28/2022 | |Date completed by author: 04/28/2022 | ||
|- | |- | ||
|Indeterminate dendritic cell tumour | |[[HAEM5:Indeterminate dendritic cell tumour|Indeterminate dendritic cell tumour]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 968: | Line 968: | ||
|NEW (No Prior) | |NEW (No Prior) | ||
|- | |- | ||
|Interdigitating dendritic cell sarcoma | |[[HAEM5:Interdigitating dendritic cell sarcoma|Interdigitating dendritic cell sarcoma]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 984: | Line 984: | ||
|NEW (No Prior) | |NEW (No Prior) | ||
|- | |- | ||
|Juvenile xanthogranuloma | |[[HAEM5:Juvenile xanthogranuloma|Juvenile xanthogranuloma]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,000: | Line 1,000: | ||
|NEW (No Prior) | |NEW (No Prior) | ||
|- | |- | ||
|Erdheim-Chester disease | |[[HAEM5:Erdheim-Chester disease|Erdheim-Chester disease]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,016: | Line 1,016: | ||
|NEW (No Prior) | |NEW (No Prior) | ||
|- | |- | ||
|Rosai-Dorfman Disease | |[[HAEM5:Rosai-Dorfman Disease|Rosai-Dorfman Disease]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,032: | Line 1,032: | ||
|NEW (No Prior) | |NEW (No Prior) | ||
|- | |- | ||
|ALK-positive histiocytosis | |[[HAEM5:ALK-positive histiocytosis|ALK-positive histiocytosis]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,048: | Line 1,048: | ||
|NEW (No Prior) | |NEW (No Prior) | ||
|- | |- | ||
|Histiocytic sarcoma | |[[HAEM5:Histiocytic sarcoma|Histiocytic sarcoma]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,083: | Line 1,083: | ||
| | | | ||
|- | |- | ||
|Reactive B-cell rich lymphoid proliferations that can mimic lymphoma | |[[HAEM5:Reactive B-cell rich lymphoid proliferations that can mimic lymphoma|Reactive B-cell rich lymphoid proliferations that can mimic lymphoma]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,099: | Line 1,099: | ||
|NEW (No Prior) | |NEW (No Prior) | ||
|- | |- | ||
|IgG4-related disease | |[[HAEM5:IgG4-related disease|IgG4-related disease]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,115: | Line 1,115: | ||
|NEW (No Prior) | |NEW (No Prior) | ||
|- | |- | ||
|Unicentric Castleman disease | |[[HAEM5:Unicentric Castleman disease|Unicentric Castleman disease]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,131: | Line 1,131: | ||
|NEW (No Prior) | |NEW (No Prior) | ||
|- | |- | ||
|Idiopathic multicentric Castleman disease | |[[HAEM5:Idiopathic multicentric Castleman disease|Idiopathic multicentric Castleman disease]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,147: | Line 1,147: | ||
|NEW (No Prior) | |NEW (No Prior) | ||
|- | |- | ||
|KSHV/HHV8-associated multicentric Castleman disease | |[[HAEM5:KSHV/HHV8-associated multicentric Castleman disease|KSHV/HHV8-associated multicentric Castleman disease]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,163: | Line 1,163: | ||
|Date completed by author: 01/24/2022 | |Date completed by author: 01/24/2022 | ||
|- | |- | ||
|B-lymphoblastic leukaemia/lymphoma | |[[HAEM5:B-lymphoblastic leukaemia/lymphoma|B-lymphoblastic leukaemia/lymphoma]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,179: | Line 1,179: | ||
| | | | ||
|- | |- | ||
|B-lymphoblastic leukaemia/lymphoma with high hyperdiploidy | |[[HAEM5:B-lymphoblastic leukaemia/lymphoma with high hyperdiploidy|B-lymphoblastic leukaemia/lymphoma with high hyperdiploidy]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,195: | Line 1,195: | ||
| | | | ||
|- | |- | ||
|B-lymphoblastic leukaemia/lymphoma with hypodiploidy | |[[HAEM5:B-lymphoblastic leukaemia/lymphoma with hypodiploidy|B-lymphoblastic leukaemia/lymphoma with hypodiploidy]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,211: | Line 1,211: | ||
| | | | ||
|- | |- | ||
|B-lymphoblastic leukaemia/lymphoma with iAMP21 | |[[HAEM5:B-lymphoblastic leukaemia/lymphoma with iAMP21|B-lymphoblastic leukaemia/lymphoma with iAMP21]] | ||
|Disease | |Disease | ||
|Holli authoring - Complete? Looks like needs more editing of tables | |Holli authoring - Complete? Looks like needs more editing of tables | ||
| Line 1,227: | Line 1,227: | ||
| | | | ||
|- | |- | ||
|B-lymphoblastic leukaemia/lymphoma with BCR::ABL1 fusion | |[[HAEM5:B-lymphoblastic leukaemia/lymphoma with BCR::ABL1 fusion|B-lymphoblastic leukaemia/lymphoma with BCR::ABL1 fusion]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,243: | Line 1,243: | ||
| | | | ||
|- | |- | ||
|B-lymphoblastic leukaemia/lymphoma with BCR::ABL1-like features | |[[HAEM5:B-lymphoblastic leukaemia/lymphoma with BCR::ABL1-like features|B-lymphoblastic leukaemia/lymphoma with BCR::ABL1-like features]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,259: | Line 1,259: | ||
| | | | ||
|- | |- | ||
|B lymphoblastic leukaemia/lymphoma with KMT2A rearrangement | |[[HAEM5:B lymphoblastic leukaemia/lymphoma with KMT2A rearrangement|B lymphoblastic leukaemia/lymphoma with KMT2A rearrangement]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,275: | Line 1,275: | ||
| | | | ||
|- | |- | ||
|B lymphoblastic leukaemia/lymphoma with ETV6::RUNX1 fusion | |[[HAEM5:B lymphoblastic leukaemia/lymphoma with ETV6::RUNX1 fusion|B lymphoblastic leukaemia/lymphoma with ETV6::RUNX1 fusion]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,291: | Line 1,291: | ||
| | | | ||
|- | |- | ||
|B-lymphoblastic leukaemia/lymphoma with ETV6::RUNX1-like features | |[[HAEM5:B-lymphoblastic leukaemia/lymphoma with ETV6::RUNX1-like features|B-lymphoblastic leukaemia/lymphoma with ETV6::RUNX1-like features]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,307: | Line 1,307: | ||
|NEW (No Prior) | |NEW (No Prior) | ||
|- | |- | ||
|B lymphoblastic leukaemia/lymphoma with TCF3::PBX1 fusion | |[[HAEM5:B lymphoblastic leukaemia/lymphoma with TCF3::PBX1 fusion|B lymphoblastic leukaemia/lymphoma with TCF3::PBX1 fusion]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,323: | Line 1,323: | ||
| | | | ||
|- | |- | ||
|B lymphoblastic leukaemia/lymphoma with IGH::IL3 fusion | |[[HAEM5:B lymphoblastic leukaemia/lymphoma with IGH::IL3 fusion|B lymphoblastic leukaemia/lymphoma with IGH::IL3 fusion]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,339: | Line 1,339: | ||
| | | | ||
|- | |- | ||
|B lymphoblastic leukaemia/lymphoma with TCF3::HLF fusion | |[[HAEM5:B lymphoblastic leukaemia/lymphoma with TCF3::HLF fusion|B lymphoblastic leukaemia/lymphoma with TCF3::HLF fusion]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,355: | Line 1,355: | ||
|NEW (No Prior) | |NEW (No Prior) | ||
|- | |- | ||
|B-lymphoblastic leukaemia/lymphoma with other defined genetic alterations | |[[HAEM5:B-lymphoblastic leukaemia/lymphoma with other defined genetic alterations|B-lymphoblastic leukaemia/lymphoma with other defined genetic alterations]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,371: | Line 1,371: | ||
|NEW (No Prior) | |NEW (No Prior) | ||
|- | |- | ||
|B-lymphoblastic leukaemia/lymphoma, NOS | |[[HAEM5:B-lymphoblastic leukaemia/lymphoma, NOS|B-lymphoblastic leukaemia/lymphoma, NOS]] | ||
|Disease | |Disease | ||
| | | | ||